1. EachPod
EachPod
CME in Minutes: Education in Primary Care - Podcast

CME in Minutes: Education in Primary Care

 Answers in CME, 71 Broadway 2B, Suite #185 New York, NY 10006

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Primary Care by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for the busy primary care providers to cover the diagnosis, treatment, follow-up, and clinical management of various disease states. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

Science Life Sciences Health & Fitness Medicine
Update frequency
every 4 days
Average duration
17 minutes
Episodes
193
Years Active
2022 - 2025
Share to:
Gary W. Falk, MD, MS / Ikuo Hirano, MD - Enhancing Outcomes in Adults and Children With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Gary W. Falk, MD, MS / Ikuo Hirano, MD - Enhancing Outcomes in Adults and Children With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Please visit answersincme.com/HQX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the treatment of eosinophilic es…
00:12:57  |   Thu 08 Jun 2023
Jonathan Schoenfeld, MD, MPH - Evolving the Treatment Landscape in Head and Neck Squamous Cell Carcinoma: Promoting Apoptosis With Emerging Antagonists of Inhibitors of Apoptosis Proteins

Jonathan Schoenfeld, MD, MPH - Evolving the Treatment Landscape in Head and Neck Squamous Cell Carcinoma: Promoting Apoptosis With Emerging Antagonists of Inhibitors of Apoptosis Proteins

Please visit answersincme.com/EEF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in head and neck squamous cell ca…
00:14:00  |   Wed 31 May 2023
Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?

Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?

Please visit answersincme.com/EUY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in hematology-oncology and oncology…
00:15:53  |   Wed 31 May 2023
Russell D. Cohen, MD, FACG, AGAF - Changing the Course of Ulcerative Colitis: Addressing Unmet Needs Through Effective Disease Severity Assessments and New Therapeutic Strategies

Russell D. Cohen, MD, FACG, AGAF - Changing the Course of Ulcerative Colitis: Addressing Unmet Needs Through Effective Disease Severity Assessments and New Therapeutic Strategies

Please visit answersincme.com/EXY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gastroenterology discusses the…
00:13:45  |   Tue 30 May 2023
Jacqueline A. Nicholas, MD, MPH - Setting the Stage for Bruton’s Tyrosine Kinase Inhibitors in Relapsing Multiple Sclerosis: Where Does the Evidence Stand?

Jacqueline A. Nicholas, MD, MPH - Setting the Stage for Bruton’s Tyrosine Kinase Inhibitors in Relapsing Multiple Sclerosis: Where Does the Evidence Stand?

Please visit answersincme.com/BAV860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses Bruton’s t…
00:14:11  |   Thu 04 May 2023
John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm

John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm

Please visit answersincme.com/BCJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses JAK inhib…
00:15:10  |   Thu 04 May 2023
Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Novel CAR T-Cell Therapies

Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Novel CAR T-Cell Therapies

Please visit answersincme.com/QTQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in multiple myeloma discusses tre…
00:14:12  |   Fri 21 Apr 2023
Tobias Welte, MD - Lowering the Risk of Respiratory Syncytial Virus in Older Adults: Late-Stage Emerging Vaccines

Tobias Welte, MD - Lowering the Risk of Respiratory Syncytial Virus in Older Adults: Late-Stage Emerging Vaccines

Please visit answersincme.com/CTR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonary infections and vacci…
00:14:16  |   Wed 12 Apr 2023
Murat Akova, MD / Jeffrey V. Lazarus, PhD, MIH, MA - Region-Specific, Patient-Centered Strategies for Optimizing Uptake of mRNA-Based COVID-19 Vaccination

Murat Akova, MD / Jeffrey V. Lazarus, PhD, MIH, MA - Region-Specific, Patient-Centered Strategies for Optimizing Uptake of mRNA-Based COVID-19 Vaccination

Please visit answersincme.com/DMC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in infectious disease discuss the c…
00:14:44  |   Mon 10 Apr 2023
Kamala P. Tamirisa, MD, FACC, FHRS - Striving Toward Health Equity in Cardiovascular Disease: Patient-Centered Conversations to Address Social Determinants of Health in Nonvalvular Atrial Fibrillation

Kamala P. Tamirisa, MD, FACC, FHRS - Striving Toward Health Equity in Cardiovascular Disease: Patient-Centered Conversations to Address Social Determinants of Health in Nonvalvular Atrial Fibrillation

Please visit answersincme.com/REP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cardiology and a patient advoc…
00:14:09  |   Mon 10 Apr 2023
Christine E. Jones, BMBS, PhD - A Full-Throated Appeal to Personalize Care in Advanced Gastroesophageal Junction (GEJ) and Esophageal Cancers: Where Do Immunotherapy-Based Regimens Fit In?

Christine E. Jones, BMBS, PhD - A Full-Throated Appeal to Personalize Care in Advanced Gastroesophageal Junction (GEJ) and Esophageal Cancers: Where Do Immunotherapy-Based Regimens Fit In?

Please visit answersincme.com/VKP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in medical oncology discusses pat…
00:13:56  |   Mon 10 Apr 2023
Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies

Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies

Please visit answersincme.com/ADT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in thoracic oncology discusses co…
00:14:48  |   Thu 30 Mar 2023
Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D

Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D

Please visit answersincme.com/PGS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in nephrology discusses integrati…
00:12:39  |   Thu 30 Mar 2023
George L. Bakris, MD, MA / Paul P. Doghramji, MD, FAAFP - Enhancing Patient Outcomes in CKD: Recognizing the Importance of Early Detection and Optimized Management

George L. Bakris, MD, MA / Paul P. Doghramji, MD, FAAFP - Enhancing Patient Outcomes in CKD: Recognizing the Importance of Early Detection and Optimized Management

Please visit answersincme.com/DCF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts in chronic kidney disease discu…
00:12:36  |   Mon 27 Mar 2023
Christine E. Jones, BMBS, PhD - Preventing Congenital Cytomegalovirus Through Behavioral and Emerging Vaccination Strategies

Christine E. Jones, BMBS, PhD - Preventing Congenital Cytomegalovirus Through Behavioral and Emerging Vaccination Strategies

Please visit answersincme.com/BZR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pediatric infectious diseases …
00:13:42  |   Mon 27 Mar 2023
Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis

Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis

Please visit answersincme.com/QWR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses the evid…
00:13:09  |   Thu 16 Mar 2023
Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy

Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy

Please visit answersincme.com/FVG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses the clin…
00:13:56  |   Thu 16 Mar 2023
Richard Finn, MD - Real Talk About CDK4/6 Inhibitors in the Treatment of HR+/HER2- Advanced Breast Cancer: Using Real-World Evidence to Impact Patient Outcomes

Richard Finn, MD - Real Talk About CDK4/6 Inhibitors in the Treatment of HR+/HER2- Advanced Breast Cancer: Using Real-World Evidence to Impact Patient Outcomes

Please visit answersincme.com/WWC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the use of …
00:16:09  |   Wed 15 Feb 2023
George Oral Waring IV, MD, FACS - Up Close With Presbyopia: Novel Emerging Miotic Agents for Aging Eyes

George Oral Waring IV, MD, FACS - Up Close With Presbyopia: Novel Emerging Miotic Agents for Aging Eyes

Please visit answersincme.com/EUA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses new tr…
00:12:58  |   Mon 16 Jan 2023
Marc E. Rothenberg, MD, PhD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Marc E. Rothenberg, MD, PhD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Please visit answersincme.com/WBE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in allergy and immunology discuss…
00:13:41  |   Mon 09 Jan 2023
Disclaimer: The podcast and artwork embedded on this page are the property of Answers in CME, 71 Broadway 2B, Suite #185 New York, NY 10006. This content is not affiliated with or endorsed by eachpod.com.